rule

Cue Biopharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 07, 2026 19:07 ET  | Source: Cue Biopharma, Inc. BOSTON, May 07, 2026 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc.…

5 days ago

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 05, 2026 07:01 ET  | Source: Invivyd NEW HAVEN, Conn., May 05, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq:…

1 week ago

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

May 01, 2026 17:30 ET  | Source: ZENTALIS PHARMACEUTICALS SAN DIEGO, May 01, 2026 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq:…

2 weeks ago

VerifyVASP acquires Sygna, consolidating the global Travel Rule network

SINGAPORE, April 29, 2026 /PRNewswire/ -- VerifyVASP, a leading Travel Rule solution provider, today announced the acquisition of Sygna, a…

2 weeks ago

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 24, 2026 08:00 ET  | Source: Aligos Therapeutics SOUTH SAN FRANCISCO, Calif., April 24, 2026 (GLOBE NEWSWIRE) -- Aligos…

3 weeks ago

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

April 03, 2026 16:01 ET  | Source: Syndax Pharmaceuticals, Inc. NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals…

1 month ago

IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

April 03, 2026 16:00 ET  | Source: IN8bio, Inc NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- IN8bio, Inc. (the…

1 month ago

Zevra Therapeutics Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)

March 20, 2026 16:30 ET  | Source: Zevra Therapeutics BOSTON, March 20, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS:…

2 months ago

FITEQ introduces new rule changes in Teqball for 2026

BUDAPEST, Hungary, March 18, 2026 /PRNewswire/ -- FITEQ, the governing body of Teqball, has announced significant rule changes effective May…

2 months ago

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PRINCETON, N.J., March 06, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and…

2 months ago